Skills Alliance Revenue and Competitors
Estimated Revenue & Valuation
- Skills Alliance's estimated annual revenue is currently $20.9M per year.
- Skills Alliance's estimated revenue per employee is $132,000
Employee Data
- Skills Alliance has 158 Employees.
- Skills Alliance grew their employee count by 48% last year.
Skills Alliance's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | VP - Consulting | Reveal Email/Phone |
4 | SVP, East Coast - New York | Reveal Email/Phone |
5 | VP, Program Delivery | Reveal Email/Phone |
6 | Head US Commercial | Reveal Email/Phone |
7 | SVP - North American Staffing | Reveal Email/Phone |
8 | VP - Medical & Clinical Development | Reveal Email/Phone |
9 | VP - East Coast | Pre-Clinical I Scientific | Executive Search | Reveal Email/Phone |
10 | Associate Director Global Learning and Development | Reveal Email/Phone |
Skills Alliance Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1M | 14 | 0% | N/A | N/A |
#2 | $3.9M | 41 | 28% | N/A | N/A |
#3 | $4.8M | 50 | -12% | N/A | N/A |
#4 | $1.7M | 20 | 0% | N/A | N/A |
#5 | $0.9M | 12 | 0% | N/A | N/A |
#6 | $4.4M | 46 | -40% | N/A | N/A |
#7 | $4.1M | 43 | 39% | N/A | N/A |
#8 | $12.8M | 107 | 8% | N/A | N/A |
#9 | $1.7M | 20 | 11% | N/A | N/A |
#10 | $7M | 65 | 12% | N/A | N/A |
What Is Skills Alliance?
Established in 2005, Skills Alliance was conceived to take advantage of a surge in demand for talented pharmaceutical industry professionals, to drive the development and bringing to market of new pharmaceutical compounds. From the outset we have fostered a culture of delivering excellence in service, using the latest recruitment methodologies available, whilst maintaining transparency and accountability every step of the way. Our internal structure is set up to mirror the full drug development life-cycle, with specialist teams responsible for each vertical area, from the pre-clinical discovery phase through to the commercialisation of the drug. To date we count many of the leading pharmaceutical, biotechnology, biopharma and CROs as our partners, and we are proud to be contributing to the discovery, development and distribution of safe and effective therapeutics across the globe. A specialist area of focus for the team at Skills Alliance is Business Transformation and EMEA / Global launch projects. We offer a bespoke solution designed to assist fast growing Biotechnology & Pharmaceutical companies in securing the best possible executive staff for their business. This ranges from new project launch teams for impending drug approvals through to full global or EMEA management build out projects. Specialist Disciplines Include: Drug Discovery and R&D Clinical Research Pharmaceutical Quality Assurance Clinical Data Management Biostatistics Drug Safety and Pharmacovigilance Regulatory Affairs Medical Information Medical Affairs Pharmaceutical Manufacturing Health Economics and Outcomes Research Government Affairs & Policy Medical Devices and Technology Regional Locations: London New York Seattle California Zurich For more information, please contact one of the leadership team members - call +44 207 220 6200 / +1 646-492-5300 or email info@skillsalliance.com
keywords:N/AN/A
Total Funding
158
Number of Employees
$20.9M
Revenue (est)
48%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Skills Alliance News
Acuff, executive director of Alliance Family YMCA and ... as to help students to develop problem-solving skills and empower their lives.
The Braver Angels Connecticut Alliance encourages residents to attend national Braver Angels eventsworkshops, book and film clubs, national...
Students showcase their skills in twelve events centered on soft skills required to get and keep a quality job.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $27.8M | 158 | 7% | N/A |
#2 | $25.2M | 158 | 3% | N/A |
#3 | $56.1M | 158 | 20% | N/A |
#4 | $46.9M | 158 | 5% | N/A |
#5 | $46.9M | 158 | 7% | N/A |